Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_assertion type Assertion NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_head.
- NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_assertion wasGeneratedBy ECO_0000203 NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_provenance.
- NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_assertion wasDerivedFrom befree-20150227 NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_provenance.
- NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_assertion SIO_000772 24577808 NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_provenance.
- NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_assertion evidence source_evidence_literature NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_provenance.
- NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_assertion description "[In addition to hydroxyurea, second-line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited number of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP310230.RAZVFXRN0ds-qf907tn137Cwz251EkaSHdbfQR_0J86uE130_provenance.